Rehearing Denied in Federal Circuit’s Ruling Against Tecfidera® Patent for Lack of Written Description

April 4, 2022

Abstract Genetics Disease - 3d rendered image. Hologram view. SEM (TEM) macroscope image. DNA mutations. Vexas disease. Medicine Healthcare research concept. X chromosomes objects.

PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells

March 7, 2022

Is Silence Disclosure?

February 8, 2022

PTAB Agrees to Review Novartis’ Patent for an Ophthalmic Injection Syringe

November 5, 2021

Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million

October 7, 2021

Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy

September 14, 2021

Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extension Guidelines Unveiled For Comments

August 25, 2021

American Gene Technologies Celebrates Milestone in HIV Cure Development

July 30, 2021

Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform

July 26, 2021

‘The Sky is [Not] Falling,’ Federal Circuit Urges as it Continues to Dismantle Broad Pharmaceutical Patents

July 1, 2021

Connect:

Subscribe:

Blogs

Firm/Org

Rothwell Figg